Mesoblast Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: -0.027x

Mesoblast Ltd cash flow conversion efficiency. Based on the latest financial reports, Mesoblast Ltd (MSB) has a cash flow conversion efficiency ratio of -0.027x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-15.56 Million ≈ $-11.01 Million USD) by net assets (AU$574.68 Million ≈ $406.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Mesoblast Ltd (2005–2025)

Cash flow conversion efficiency of Mesoblast Ltd from 2005 to 2025. This chart illustrates how Mesoblast Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Mesoblast Ltd for real-time trading data and today's change.

Mesoblast Ltd Cash Flow Conversion Ratio Explained

Mesoblast Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Mesoblast Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mesoblast Ltd ranked by their cash flow conversion efficiency. Also see Mesoblast Ltd stock valuation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Domain Holdings Australia Ltd
AU:DHG
0.049x
Maanshan Iron & Steel Co Ltd
SHG:600808
-0.004x
Great Wall Motor Company Limited
F:GRV
0.066x
Anhui Heli Co Ltd
SHG:600761
0.035x
Zhejiang Daily Media Group Co Ltd
SHG:600633
0.007x
King’s Town Bank
TW:2809
0.025x
Kunshan Kersen Science & Tech
SHG:603626
0.055x
AVI LTD (UNSP.ADR)/5
F:IZ60
N/A

Annual Cash Flow Conversion Efficiency for Mesoblast Ltd (2005–2025)

The table below shows the annual cash flow conversion efficiency of Mesoblast Ltd from 2005 to 2025. Review MSB free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$597.44 Million
≈ $422.73 Million
AU$-49.95 Million
≈ $-35.35 Million
-0.084x +17.12%
2024-06-30 AU$480.36 Million
≈ $339.88 Million
AU$-48.46 Million
≈ $-34.29 Million
-0.101x +19.98%
2023-06-30 AU$501.84 Million
≈ $355.08 Million
AU$-63.27 Million
≈ $-44.77 Million
-0.126x +4.74%
2022-06-30 AU$497.04 Million
≈ $351.69 Million
AU$-65.78 Million
≈ $-46.54 Million
-0.132x +27.87%
2021-06-30 AU$581.40 Million
≈ $411.38 Million
AU$-106.68 Million
≈ $-75.48 Million
-0.183x -78.83%
2020-06-30 AU$549.33 Million
≈ $388.68 Million
AU$-56.37 Million
≈ $-39.88 Million
-0.103x +14.59%
2019-06-30 AU$481.05 Million
≈ $340.37 Million
AU$-57.79 Million
≈ $-40.89 Million
-0.120x +12.56%
2018-06-30 AU$546.01 Million
≈ $386.34 Million
AU$-75.01 Million
≈ $-53.08 Million
-0.137x +25.64%
2017-06-30 AU$516.77 Million
≈ $365.64 Million
AU$-95.47 Million
≈ $-67.55 Million
-0.185x -10.89%
2016-06-30 AU$528.16 Million
≈ $373.71 Million
AU$-88.00 Million
≈ $-62.26 Million
-0.167x +16.58%
2015-06-30 AU$609.36 Million
≈ $431.16 Million
AU$-121.71 Million
≈ $-86.12 Million
-0.200x -39.49%
2014-06-30 AU$571.72 Million
≈ $404.53 Million
AU$-81.86 Million
≈ $-57.92 Million
-0.143x -66.87%
2013-06-30 AU$630.27 Million
≈ $445.95 Million
AU$-54.08 Million
≈ $-38.27 Million
-0.086x +43.03%
2012-06-30 AU$478.85 Million
≈ $338.82 Million
AU$-72.12 Million
≈ $-51.03 Million
-0.151x -171.78%
2011-06-30 AU$515.84 Million
≈ $364.99 Million
AU$108.23 Million
≈ $76.58 Million
0.210x +182.38%
2010-06-30 AU$37.92 Million
≈ $26.83 Million
AU$-9.66 Million
≈ $-6.83 Million
-0.255x +28.89%
2009-06-30 AU$25.79 Million
≈ $18.25 Million
AU$-9.24 Million
≈ $-6.54 Million
-0.358x -51.39%
2008-06-30 AU$26.22 Million
≈ $18.55 Million
AU$-6.20 Million
≈ $-4.39 Million
-0.237x +46.61%
2007-06-30 AU$20.54 Million
≈ $14.53 Million
AU$-9.10 Million
≈ $-6.44 Million
-0.443x -66.55%
2006-06-30 AU$11.97 Million
≈ $8.47 Million
AU$-3.18 Million
≈ $-2.25 Million
-0.266x -747.50%
2005-06-30 AU$19.26 Million
≈ $13.63 Million
AU$-604.81K
≈ $-427.94K
-0.031x --

About Mesoblast Ltd

AU:MSB Australia Biotechnology
Market Cap
$1.98 Billion
AU$2.80 Billion AUD
Market Cap Rank
#5949 Global
#143 in Australia
Share Price
AU$2.16
Change (1 day)
+0.00%
52-Week Range
AU$1.76 - AU$3.07
All Time High
AU$5.21
About

Mesoblast Limited, together with its subsidiaries, engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland. The company's proprietary regenerative medicine technology platform is based on specialized cells known as mesenchymal lineage cells. It offers Remestemcel-L, which is in Phase III clinical trials for the treatment of systemic… Read more